- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
NAFLD & NASH in Primary Care: Facts, Definitions, & Figures in Brief
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is increasing and early detection is critical. Brush up on basics with our slides.
Clinicians in primary care, diabetes, and obesity settings should have a high index of suspicion for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), according to the American Association for the Study of Liver Diseases (AASLD). NAFLD prevalence has increased in lock-step with the obesity pandemic and one- to two-thirds of patients with type 2 diabetes have the disorder.
A data‐supported approach to the diagnosis, treatment, and prevention of NAFLD is provided in a guidance document from the AASLD published in Hepatology. For a brief summary of the basic NAFLD/NASH facts and figures, click through the slides below.
